Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Mogg AJ"'
Publikováno v:
British Journal of Pharmacology. Feb2013, Vol. 168 Issue 4, p1015-1029. 15p. 3 Charts, 7 Graphs.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Schuelert N, Zhang C, Mogg AJ, Broad LM, Hepburn DL, Nisenbaum ES, Johnson MP, McDougall JJ, Schuelert, N, Zhang, C, Mogg, A J, Broad, L M, Hepburn, D L, Nisenbaum, E S, Johnson, M P, McDougall, J J
Publikováno v:
Osteoarthritis & Cartilage; Nov2010, Vol. 18 Issue 11, p1536-1543, 8p
Autor:
Allison M; Biodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, United Kingdom., Davie RL; KalVista Pharmaceuticals Limited, Salisbury, SP4 0BF, United Kingdom., Mogg AJ; KalVista Pharmaceuticals Limited, Salisbury, SP4 0BF, United Kingdom., Hampton SL; KalVista Pharmaceuticals Limited, Salisbury, SP4 0BF, United Kingdom., Emsley J; Biodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, United Kingdom., Stocks MJ; Biodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, United Kingdom.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2024 Mar 28; Vol. 15 (4), pp. 501-509. Date of Electronic Publication: 2024 Mar 28 (Print Publication: 2024).
Autor:
Lu S; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Building 10, Room B3C346, 10 Center Drive, Bethesda, MD 20892-1003, USA., Haskali MB; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Building 10, Room B3C346, 10 Center Drive, Bethesda, MD 20892-1003, USA., Ruley KM; Eli Lilly and Co, Indianapolis, IN 46285, USA., Dreyfus NJ; Eli Lilly and Co, Windlesham GU20 6PH, UK., DuBois SL; Eli Lilly and Co, Indianapolis, IN 46285, USA., Paul S; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Building 10, Room B3C346, 10 Center Drive, Bethesda, MD 20892-1003, USA., Liow JS; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Building 10, Room B3C346, 10 Center Drive, Bethesda, MD 20892-1003, USA., Morse CL; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Building 10, Room B3C346, 10 Center Drive, Bethesda, MD 20892-1003, USA., Kowalski A; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Building 10, Room B3C346, 10 Center Drive, Bethesda, MD 20892-1003, USA., Gladding RL; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Building 10, Room B3C346, 10 Center Drive, Bethesda, MD 20892-1003, USA., Gilmore J; Eli Lilly and Co, Windlesham GU20 6PH, UK., Mogg AJ; Eli Lilly and Co, Windlesham GU20 6PH, UK., Morin SM; Eli Lilly and Co, Indianapolis, IN 46285, USA., Lindsay-Scott PJ; Eli Lilly and Co, Windlesham GU20 6PH, UK., Ruble JC; Eli Lilly and Co, Indianapolis, IN 46285, USA., Kant NA; Eli Lilly and Co, Indianapolis, IN 46285, USA., Shcherbinin S; Eli Lilly and Co, Indianapolis, IN 46285, USA., Barth VN; Eli Lilly and Co, Indianapolis, IN 46285, USA., Johnson MP; Eli Lilly and Co, Indianapolis, IN 46285, USA., Cuadrado M; Lilly, S. A. Avenida de la Industria 30, 28108 Alcobendas, Madrid, Spain., Jambrina E; Lilly, S. A. Avenida de la Industria 30, 28108 Alcobendas, Madrid, Spain., Mannes AJ; Department of Perioperative Medicine, Clinical Center, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892-1510, USA., Nuthall HN; Eli Lilly and Co, Windlesham GU20 6PH, UK., Zoghbi SS; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Building 10, Room B3C346, 10 Center Drive, Bethesda, MD 20892-1003, USA., Jesudason CD; Eli Lilly and Co, Indianapolis, IN 46285, USA., Innis RB; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Building 10, Room B3C346, 10 Center Drive, Bethesda, MD 20892-1003, USA., Pike VW; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Building 10, Room B3C346, 10 Center Drive, Bethesda, MD 20892-1003, USA. pikev@mail.nih.gov.
Publikováno v:
Science translational medicine [Sci Transl Med] 2020 May 13; Vol. 12 (543).
Autor:
Bradley SJ; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK. sophie.bradley@glasgow.ac.uk., Molloy C; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Valuskova P; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Dwomoh L; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Scarpa M; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Rossi M; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Finlayson L; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Svensson KA; Eli Lilly & Co, Neuroscience Discovery, Lilly Corporate Center, Indianapolis, IN, USA., Chernet E; Eli Lilly & Co, Neuroscience Discovery, Lilly Corporate Center, Indianapolis, IN, USA., Barth VN; Eli Lilly & Co, Neuroscience Discovery, Lilly Corporate Center, Indianapolis, IN, USA., Gherbi K; School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, UK.; Excellerate Bioscience Ltd, BioCity, Nottingham, UK., Sykes DA; School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, UK.; Centre of Membrane and Protein and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK., Wilson CA; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK., Mistry R; Department of Molecular and Cell Biology, Henry Wellcome Building, University of Leicester, Leicester, UK., Sexton PM; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia., Christopoulos A; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia., Mogg AJ; Eli Lilly & Co, Neuroscience Discovery, Lilly Corporate Center, Indianapolis, IN, USA., Rosethorne EM; School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, UK.; Centre of Membrane and Protein and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK., Sakata S; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK., John Challiss RA; Department of Molecular and Cell Biology, Henry Wellcome Building, University of Leicester, Leicester, UK., Broad LM; Eli Lilly & Co, Neuroscience Discovery, Erl Wood Manor, Windlesham, Surrey, UK., Tobin AB; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK. andrew.tobin@glasgow.ac.uk.
Publikováno v:
Nature chemical biology [Nat Chem Biol] 2020 Mar; Vol. 16 (3), pp. 240-249. Date of Electronic Publication: 2020 Feb 20.
Autor:
Broad LM; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK., Sanger HE; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK., Mogg AJ; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK., Colvin EM; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK., Zwart R; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK., Evans DA; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK., Pasqui F; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK., Sher E; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK., Wishart GN; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK., Barth VN; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Felder CC; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Goldsmith PJ; Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, UK.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2019 Jan; Vol. 176 (1), pp. 110-126. Date of Electronic Publication: 2018 Nov 16.
Autor:
Felder CC; Eli Lilly & Co., Indianapolis, IN, USA. Electronic address: christianfelder@gmail.com., Goldsmith PJ; Eli Lilly & Co., Windlesham, Surrey, UK., Jackson K; Eli Lilly & Co., Windlesham, Surrey, UK., Sanger HE; Eli Lilly & Co., Windlesham, Surrey, UK., Evans DA; Eli Lilly & Co., Windlesham, Surrey, UK., Mogg AJ; Eli Lilly & Co., Windlesham, Surrey, UK., Broad LM; Eli Lilly & Co., Windlesham, Surrey, UK.
Publikováno v:
Neuropharmacology [Neuropharmacology] 2018 Jul 01; Vol. 136 (Pt C), pp. 449-458. Date of Electronic Publication: 2018 Jan 31.